Literature DB >> 8142259

Prospective evaluation of cell kinetics in head and neck squamous carcinoma: the relationship to tumour factors and survival.

L D Cooke1, T G Cooke, G Forster, A S Jones, P M Stell.   

Abstract

Tumour growth rates were measured in 105 patients using in vivo incorporation of bromodeoxyuridine (BrdU) and investigated for any relationship to tumour factors or survival. The median labelling index (LI) was 8.7%, the duration of S-phase (Ts) was 14 h and the potential doubling time (Tpot) was 5.9 days. The labelling index in aneuploid tumours was significantly higher than that in diploid tumours. However the total labelling index (TLI) did not differ significantly between aneuploid and diploid tumours, and so it would seem likely that the difference in LI is due to the dilutional effect of benign tissue upon the calculation of LI in diploid tumours. The total labelling index, duration of S-phase and potential doubling time were not related to the tumour factors examined (site, T stage, N stage, stage grouping). Interim survival analysis was carried out and there was no difference in survival between those patients with high values for TLI, Ts, and Tpot and those with low values.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8142259      PMCID: PMC1968830          DOI: 10.1038/bjc.1994.135

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Cellular DNA content parameters in untreated and recurrent squamous cell cancers of the head and neck.

Authors:  J F Ensley; Z Maciorowski; M Hassan; H Pietraszkiewicz; L Heilbrun; J A Kish; E Tapazoglou; J R Jacobs; M al-Sarraf
Journal:  Cytometry       Date:  1989-05

2.  A method to measure the duration of DNA synthesis and the potential doubling time from a single sample.

Authors:  A C Begg; N J McNally; D C Shrieve; H Kärcher
Journal:  Cytometry       Date:  1985-11

3.  Flow cytometric analysis of head and neck carcinoma DNA index and S-fraction from paraffin-embedded sections: comparison with malignancy grading.

Authors:  T S Johnson; K D Williamson; M M Cramer; L J Peters
Journal:  Cytometry       Date:  1985-09

4.  A Phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation.

Authors:  T J Kinsella; A Russo; J B Mitchell; J Rowland; J Jenkins; J Schwade; C E Myers; J M Collins; J Speyer; P Kornblith
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-01       Impact factor: 7.038

5.  Variability of the thymidine labeling index in squamous cell carcinoma of the head and neck.

Authors:  B Greenberg; L Woo; S Blatchford; M Aguirre; H Garewal
Journal:  Laryngoscope       Date:  1988-06       Impact factor: 3.325

6.  Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.

Authors:  A Riccardi; M Danova; G Wilson; G Ucci; P Dörmer; G Mazzini; S Brugnatelli; M Girino; N J McNally; E Ascari
Journal:  Cancer Res       Date:  1988-11-01       Impact factor: 12.701

7.  Short-term variation in labeling index as a predictor of radiotherapy response in human oral cavity carcinoma.

Authors:  R Silvestrini; R Molinari; A Costa; F Volterrani; G Gardani
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-07       Impact factor: 7.038

8.  Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck.

Authors:  M H Bennett; G D Wilson; S Dische; M I Saunders; C A Martindale; B M Robinson; A E O'Halloran; M D Leslie; J H Laing
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

9.  DNA measurement--an objective predictor of response to irradiation? A review of 24 squamous cell carcinomas of the oral cavity.

Authors:  G Franzén; C Klintenberg; J Olofsson; B Risberg
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

View more
  3 in total

Review 1.  Biomarkers of head and neck cancer, tools or a gordian knot?

Authors:  Evangeli S Lampri; Georgios Chondrogiannis; Elli Ioachim; Anna Varouktsi; Antigoni Mitselou; Aggeliki Galani; Evangelos Briassoulis; Panagiotis Kanavaros; Vasiliki Galani
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Potential tumour doubling time: determination of Tpot for various canine and feline tumours.

Authors:  U Schwyn; N E Crompton; H Blattmann; B Hauser; B Klink; A Parvis; D Ruslander; B Kaser-Hotz
Journal:  Vet Res Commun       Date:  1998-06       Impact factor: 2.459

3.  Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis.

Authors:  F Janot; J Klijanienko; A Russo; J P Mamet; F de Braud; A K El-Naggar; J P Pignon; B Luboinski; E Cvitkovic
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.